KPTI logo

Karyopharm Therapeutics (KPTI) Current Liabilities

Annual Current Liabilities

$92.26 M
+$22.79 M+32.79%

December 31, 2024

Summary

Performance

1-Year Change

+32.79%

3-Year Change

+25.16%

5-Year Change

+99.06%

15-Year Change

+86.52%

KPTI Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

75.82%
KPTI annual total current liabilities is higher than 75.82% of companies in Healthcare sector

High & Low

All-time High

$92.26 M
KPTI annual total current liabilities is currently at an all-time high

3-Year Low

$65.91 M
KPTI annual total current liabilities is currently +39.99% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KPTI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KPTI next annual earnings announcement has not yet been scheduled

OtherKPTIbalance sheetmetrics:

Annual Total Liabilities

$350.44 M
KPTI annual total liabilities is $350.44 million

Annual Total Long Term Liabilities

$258.17 M
KPTI annual total long term liabilities is $258.17 million

Annual Total Assets

$164.42 M
KPTI annual total assets is $164.42 million

Annual Current Assets

$156.49 M
KPTI annual total current assets is $156.49 million

Quarterly Current Liabilities

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

KPTI Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$73.72 M
KPTI quarterly total current liabilities is currently at an all-time high

3-Year Low

$57.62 M
KPTI quarterly total current liabilities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KPTI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
KPTI next earnings announcement has not yet been scheduled

OtherKPTIbalance sheetmetrics:

Quarterly Total Liabilities

$350.44 M
KPTI quarterly total liabilities is $350.44 million

Quarterly Long Term Liabilities

-
KPTI quarterly total long term liabilities value is unknown

Quarterly Total Assets

$164.42 M
KPTI quarterly total assets is $164.42 million

Quarterly Current Assets

-
KPTI quarterly total current assets value is unknown

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$92.26 M
KPTI annual total current liabilities is $92.26 million

Annual Accounts Payable

$5.11 M
KPTI annual accounts payable is $5.11 million

Annual Short Term Debt

$24.86 M
KPTI annual short term debt is $24.86 million

KPTI Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+32.8%-
3 y3 years+25.2%-
5 y5 years+99.1%-

KPTI Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+40.0%
5 y5-yearat high+99.1%
alltimeall timeat high+4680.5%

Karyopharm Therapeutics Current Liabilities History

DateAnnualQuarterly
Dec 2024
$92.26 M(+32.8%)
-
Sep 2024
-
$61.49 M(+6.7%)
Jun 2024
-
$57.62 M(-11.8%)
Mar 2024
-
$65.34 M(-6.0%)
Dec 2023
$69.48 M(+5.4%)
$69.48 M(+11.9%)
Sep 2023
-
$62.08 M(+5.3%)
Jun 2023
-
$58.93 M(-4.3%)
Mar 2023
-
$61.55 M(-6.6%)
Dec 2022
$65.91 M(-10.6%)
$65.91 M(+6.7%)
Sep 2022
-
$61.76 M(-1.2%)
Jun 2022
-
$62.54 M(-5.7%)
Mar 2022
-
$66.34 M(-10.0%)
Dec 2021
$73.72 M(+22.4%)
$73.72 M(+7.0%)
Sep 2021
-
$68.87 M(+18.5%)
Jun 2021
-
$58.12 M(-6.3%)
Mar 2021
-
$62.01 M(+3.0%)
Dec 2020
$60.20 M(+29.9%)
$60.20 M(+14.4%)
Sep 2020
-
$52.63 M(+4.1%)
Jun 2020
-
$50.57 M(+1.8%)
Mar 2020
-
$49.70 M(+7.2%)
Dec 2019
$46.35 M(-1.2%)
$46.35 M(+18.2%)
Sep 2019
-
$39.20 M(+21.8%)
Jun 2019
-
$32.17 M(-26.6%)
Mar 2019
-
$43.86 M(-6.5%)
DateAnnualQuarterly
Dec 2018
$46.90 M(-5.2%)
$46.90 M(+12.8%)
Sep 2018
-
$41.57 M(+13.7%)
Jun 2018
-
$36.54 M(-21.8%)
Mar 2018
-
$46.73 M(-5.5%)
Dec 2017
$49.47 M(+200.2%)
$49.47 M(+133.8%)
Sep 2017
-
$21.16 M(+20.7%)
Jun 2017
-
$17.52 M(+13.2%)
Mar 2017
-
$15.48 M(-6.0%)
Dec 2016
$16.48 M(+8.9%)
$16.48 M(+10.2%)
Sep 2016
-
$14.95 M(-3.7%)
Jun 2016
-
$15.52 M(+17.4%)
Mar 2016
-
$13.22 M(-12.6%)
Dec 2015
$15.13 M(+23.0%)
$15.13 M(+4.8%)
Sep 2015
-
$14.44 M(+2.4%)
Jun 2015
-
$14.10 M(-4.1%)
Mar 2015
-
$14.70 M(+19.5%)
Dec 2014
$12.30 M(+273.7%)
$12.30 M(+97.3%)
Sep 2014
-
$6.23 M(+10.4%)
Jun 2014
-
$5.65 M(+12.6%)
Mar 2014
-
$5.01 M(+52.3%)
Dec 2013
$3.29 M(+70.6%)
$3.29 M(-17.6%)
Sep 2013
-
$4.00 M(+57.3%)
Jun 2013
-
$2.54 M(+31.7%)
Dec 2012
$1.93 M(-8.8%)
$1.93 M
Dec 2011
$2.12 M
-

FAQ

  • What is Karyopharm Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics annual current liabilities year-on-year change?
  • What is the all time high quarterly current liabilities for Karyopharm Therapeutics?

What is Karyopharm Therapeutics annual total current liabilities?

The current annual current liabilities of KPTI is $92.26 M

What is the all time high annual current liabilities for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual total current liabilities is $92.26 M

What is Karyopharm Therapeutics annual current liabilities year-on-year change?

Over the past year, KPTI annual total current liabilities has changed by +$22.79 M (+32.79%)

What is the all time high quarterly current liabilities for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly total current liabilities is $73.72 M